<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR96">
 <label>96.</label>
 <mixed-citation publication-type="other">Liu F, Xu A, Zhang Y, Xuan W, Yan T, Pan K, Yu W, Zhang J. Patients of COVID-19 may benefit from sustained lopinavir-combined regimen and the increase of eosinophil may predict the outcome of COVID-19 progression. Int J Infect Dis. 2020;95:183â€“91.</mixed-citation>
</ref>
